Table 2. Response to BVD therapy (n=70 evaluable).
Response | After four cycles, n (%) | Best response, n (%) |
---|---|---|
CR | 11 (16) | 14 (20) |
VGPR | 13 (18.5) | 14 (20) |
PR | 26 (37) | 26 (37) |
SD | 14 (20) | 14 (20) |
PD | 6 (8.5) | 2 (3) |
At least PR | 50 (71.5) | 54 (77) |
Abbreviations: BVD, bendamustine plus bortezomib and dexamethasone; CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease; VGPR, very good partial response.